Glipizide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Ertugliflozin: Cardioprotective Effects on Epicardial Fat
Conditions:   Cardiovascular Diseases;   Atherosclerosis;   Type 2 Diabetes;   Insulin Resistance Interventions:   Drug: Ertugliflozin;   Drug: Glipizide Sponsors:   Stanford University;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2019 Category: Research Source Type: clinical trials

A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Condition:   Type 2 Diabetes MellitusInterventions:   Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Glipizide;   Drug: Placebo to glipizide;   Biological: InsulinSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2012 Category: Research Source Type: clinical trials

A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Condition:   Type 2 Diabetes MellitusInterventions:   Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Glipizide;   Drug: Placebo to glipizide;   Biological: InsulinSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2012 Category: Research Source Type: clinical trials